Mawson Infrastructure Group Faces Backlash from Endeavor Investor Group Over Poison Pill Defense

Thursday, Feb 5, 2026 11:06 pm ET1min read
MIGI--

Endeavor Investor Group has condemned Mawson Infrastructure Group's adoption of a stockholder rights plan, calling it a move to protect management at the expense of shareholders. Endeavor criticized the board for shielding itself from accountability instead of addressing operational underperformance. Mawson implemented the plan to prevent a takeover without a control premium after Endeavor and its affiliates reported a combined ownership of roughly 48% as of January 30. The rights plan triggers if an entity acquires 20% or more of the outstanding common stock, allowing other shareholders to purchase shares at a 50% discount.

Mawson Infrastructure Group Faces Backlash from Endeavor Investor Group Over Poison Pill Defense

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet